血液透析患者应用促红素的护理效果观察
Observation of the effect of erythropoietin in hemodialysis patients
管丽莉 1张旭环1
作者信息
- 1. 武警浙江总队嘉兴医院 血透室,浙江 嘉兴 314000
- 折叠
摘要
目的 观察促红素在维持血液透析的肾性贫血患者的应用机制,总结围治疗期护理干预对策.方法 选取2015年6月~2017年6月武警浙江总队嘉兴医院收治的60例维持血液透析的肾性贫血患者为研究对象,随机分为对照组与研究组,各30例,2组均行常规剂量的促红细胞生成素(EPO)治疗后,研究组在对照组基础上加入针对性护理干预,比较2组患者治疗效果.结果 研究组治疗6个月后红细胞比容(Hct)、血红细胞(Hb)改善效果明显优于对照组(P<0.05).结论 促红素应用于维持血液透析的肾性贫血患者中具有一定疗效,同时围治疗期加入针对性护理干预,有助于改善患者机体血红细胞表现.
Abstract
Objective To observe the effect of erythropoietin in maintenance hemodialysis patients with application of the mechanism of renal anemia, summarize the perioperative nursing intervention measures. Methods 60 cases from June 2016 to June 2017 in our hospital undergoing maintenance hemodialysis patients with renal anemia as the research object, randomly divided into control group and study group with 30 cases in each group, erythropoietin cells in two groups were treated with conventional dose hormone (EPO) after treatment, the study group on the basis of the control group with specific nursing intervention, compared two groups of patients with therapeutic effect. Results The treatment group hematocrit after 6 treatment months (Hct), red blood cell (Hb) was obviously better than that of control group (P<0.05). Conclusion The application of erythropoietin in hemodialysis patients with renal anemia has certain curative effect, and perioperative with targeted nursing intervention is helpful to improve the blood red cells of patients with clinical manifestations, with significant value.
关键词
促红素/血液透析/肾性贫血/护理干预Key words
erythropoietin (EPO)/hemodialysis/renal anemia/nursing intervention引用本文复制引用
出版年
2017
NETL
NSTL
维普
万方数据